EUCTR2011-003185-33-IT进行中（未招募）不适用
Prospective, controlled, randomized, blind study to evaluate the effects of intramuscular-paravertebral injections of an oxygen-ozone (O2-O3) mixture in patients with lumbar pain aged 65 or older - O2-O3 Therapy
ISTITUTO NAZIONALE DI RICOVERO E CURA PER ANZIANI IRCCS0 个研究点开始时间: 2012年3月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. subjects aged 65 or older 2. lumbar pain and discopathy for at least 6 weeks 3.Patients with diagnostic imaging performed by no longer than two years to exclude the presence of diseases or morphological conditions listed in the exclusion criteria 4. Oswestry Disability Index between 30% and 80% 5. Patients free from steroidal and nonsteroidal antinflammatory drugs from at least 10 days
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 130
排除标准
- •1. clinical signs of radiculopathy 2. cauda equina syndrome 3. progressive neurologic deficit 4. lumbar stenosis 5. spondylolisthesis 6. lesions requiring immediately surgery 7. diabetic neuropathy 8. body mass index >30 9. lumbar scoliosis >20° 10. favism 11. Known or suspected hypersensitivity to paracetamol or controindications of its use
研究者
相似试验
招募中
不适用
Prospective, single-blind, randomized controlled trial on effectiveness of single balloon overtube for ESD performed right semicolon lesion.early colorectal cancerJPRN-UMIN000032803Saiseikai Nakatsu Hospital60
招募中
1 期
Prospective, randomized, clinical, controlled study to investigate the wear behavior and color change of printed composite restorationsWear behavior of composite restorationsColor change of composite restorationsDRKS00024738Charité - Universitätsmedizin BerlinCentrum 3 für Zahn-, Mund- und Kieferheilkunde, Abteilung für Zahnärztliche Prothetik, Alterszahnmedizin und Funktionslehre250
尚未招募
不适用
Prospective, randomized, clinical, controlled study to investigate the wear behavior of different prosthetic materials of single crowns.Abrasion of artificial dental crowns in comparisonthree different crown materials are testedOral health-related quality of life may be affected by prosthetic treatment.DRKS00024377Charité-Universitätsmedizin Berlin, Abteilung für Zahnärztliche Prothetik, Alterszahnmedizin und Funktionslehre69
进行中（未招募）
1 期
Blinded, randomised, controlled, multicenter study to evaluate the clinical efficacy against varicella disease of GlaxoSmithKline Biologicals’ live attenuated varicella vaccine (Varilrix) given on a one-dose schedule and of GlaxoSmithKline Biologicals’ combined measles-mumps-rubella-varicella vaccine (Priorix™-Tetra) given on a two-dose schedule in healthy children during the second year of life - OKAH179&all EXT´sHealthy children between 12-22 months (including the day before the 23-month birthday) of age at the time of vaccination with no history of measles, mumps, rubella and varicella diseases/vaccination.EUCTR2004-002676-41-SKGlaxoSmithKline Biologicals5,754
进行中（未招募）
1 期
Evaluate a Vaccine against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxHealthy children between 12-22 months (including the day before the 23-month birthday) of age at the time of vaccination with no history of measles, mumps, rubella and varicella diseases/vaccination.MedDRA version: 14.1Level: PTClassification code 10028257Term: MumpsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10046980Term: VaricellaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10039252Term: RubellaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10027011Term: MeaslesSystem Organ Class: 10021881 - Infections and infestationsEUCTR2004-002676-41-CZGlaxoSmithKline Biologicals5,754